0001209191-16-136473.txt : 20160810 0001209191-16-136473.hdr.sgml : 20160810 20160810201845 ACCESSION NUMBER: 0001209191-16-136473 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160810 FILED AS OF DATE: 20160810 DATE AS OF CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 521 COTTONWOOD DRIVE, SUITE 100 CITY: MALPITAS STATE: CA ZIP: 95035-7404 BUSINESS PHONE: 408-649-7370 MAIL ADDRESS: STREET 1: 521 COTTONWOOD DRIVE, SUITE 100 CITY: MALPITAS STATE: CA ZIP: 95035-7404 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waddill William D. CENTRAL INDEX KEY: 0001553338 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 161822734 MAIL ADDRESS: STREET 1: C/O CALITHERA BIOSCIENCES STREET 2: 343 OYSTER POINT BLVD, SUITE 200 CITY: SO. SAN FRANCISCO STATE: CA ZIP: 94080 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-08-10 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001553338 Waddill William D. C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100 MILPITAS CA 95035 1 0 0 0 Stock Option (right to buy) 6.09 2026-07-16 Common Stock 12975 D The option vests over a two-year period, with 1/24th of the shares subject to the option vesting each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. /s/ William D. Waddill 2016-08-08 EX-24.3_670529 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these present, that the undersigned hereby constitutes and appoints each of DINESH V. PATEL, PH.D., and THOMAS P. O'NEIL, signing individually, the undersigned's true and lawful attorneys-in fact and agents to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of Protagonist Therapeutics, Inc. (the "Company"), (a) Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder and a (b) Form ID, Uniform Application for Access Codes to File on EDGAR, including Update Passphrase Confirmation; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID (including any amendments thereto) and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of July 8, 2016. /s/ William D. Waddill William D. Waddill